Stratagene, Third Wave, Applera, Roche, ABI, Agilent, Bio-Rad, Qiagen, Beckman Coulter, Thermo Electron, Invitrogen | GenomeWeb

Stratagene Posts 27-Percent Increase in Q1 Revenue,
But Receipts Fall 2 Percent Ex-Hycor …

Stratagene this week reported a 27-percent increase in total revenues and increased earnings for the first quarter of 2005, but the company's core receipts fell more than 2 percent if revenue from its Hycor acquisition are excluded.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."